View EO 12866 Meeting 0938-AT02

  CY 2018 Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Part B; Medicare Shared Savings Program Requirements; Medicare Diabetes Prevention Program (CMS-1676-F)

  0938-HHS/CMS

  Final Rule Stage

  09/28/2017 01:00 PM

  Biosimilars Forum


 
List of Documents
Handout
Handout
Handout
Handout
Handout
Handout
 
List of Attendees Participation
•   Michael Werner  - H&K In Person 
•   Jennifer Alltoft  - Pfizer In Person 
•   Milanda Franco  - Holland & Knight In Person 
•   Bob Filippone  - Merck In Person 
•   Christina Swoope  - OMB/HD In Person 
•   Andy Swire  - Amgen In Person 
•   Robert Falb  - Teva In Person 
•   Brenda Aguilar  - OMB/OIRA In Person 
•   Amanda Fohrys  - Xcenda In Person 
•   Bill O'Brien  - Amgen In Person 
•   Michael Fleming  - Coherus BioSciences In Person 
•   Elyse Greenwald  - OMB/OIRA In Person 
•   Sheila Frame  - Sandoz In Person 
•   John Kraemer  - Pfizer In Person 
•   Jim Carey  - Merck In Person 
•   Juliana Reed  - Coherus BioSciences In Person 
•   Wendy Sussman  - Sandoz, NVS In Person 
•   Daniel Motto  - Teva In Person